Zobrazeno 1 - 10
of 434
pro vyhledávání: '"Christopher S Hayward"'
Autor:
Kavitha Muthiah, Jerry R Greenfield, Nicole K Bart, Peter MacDonald, Eugene Kotlyar, Christopher S Hayward, Andrew Jabbour, Lisa Mary Raven, Christopher A Muir, Cassia Kessler Iglesias
Publikováno v:
BMJ Open, Vol 13, Iss 3 (2023)
Introduction Cardiac transplantation (CTx) is a life-saving operation that can improve the quality and length of a recipient’s life. Immunosuppression medication, required to prevent rejection, can result in adverse metabolic and renal effects. Cli
Externí odkaz:
https://doaj.org/article/085437b45468456e906902249774d07a
Autor:
Sajad Shehab, Christopher S Hayward
Publikováno v:
Cardiac Failure Review, Vol 5, Iss 1, Pp 19-23 (2019)
Right ventricular failure following left ventricular assist devices implantation is a serious complication associated with high mortality. In patients with or at high risk of developing right ventricular failure, biventricular support is recommended.
Externí odkaz:
https://doaj.org/article/e90ff6f253ae4a40a1dbbabb515deef8
Autor:
Emily C Hodkinson, Melanie eNeijts, Arash eSadrieh, Mohammad S Imtiaz, Mathias eBaumert, Rajesh N Subbiah, Christopher S Hayward, Dorret eBoomsma, Gonneke eWillemsen, Jamie I Vandenberg, Adam eHill, Eco eDe Geus
Publikováno v:
Frontiers in Physiology, Vol 7 (2016)
INTRODUCTIONThe resting ECG is the most commonly used tool to assess cardiac electrophysiology. Previous studies have estimated heritability of ECG parameters based on these snapshots of the cardiac electrical activity. In this study we set out to de
Externí odkaz:
https://doaj.org/article/7fb7a1ca7cef4a7f935c52fa4631eb4c
Publikováno v:
Vascular Health and Risk Management, Vol Volume 4, Pp 1111-1113 (2008)
Anne M Keogh, Andrew Jabbour, Christopher S Hayward, Peter S MacdonaldHeart Lung Transplant Unit, St Vincent’s Hospital, Sydney, New South Wales, AustraliaAbstract: Sildenafil is a selective inhibitor of phosphodiesterase type 5 (PDE-5). Its chroni
Externí odkaz:
https://doaj.org/article/13f2c8c1b8614da29d7b5c17b7119fb5
Autor:
Sumita Barua, FRACP, Tao Yang, MBBS, MSc, PhD, FRCPA, Sean Conte, BA, MBBS, Christopher Bragg, BSc, Jacob Sevastos, BSc (Med), PhD, FRACP, Peter S. Macdonald, MBBS, FRACP, PhD, MD, FCSANZ, Kavitha Muthiah, MBChB, PhD, FRACP, FCSANZ, Christopher S. Hayward, BMedSc, MD, FRACP, FCSANZ
Publikováno v:
Transplantation Direct, Vol 9, Iss 1, p e1424 (2023)
Background. Cardiorenal syndrome (CRS) contributes significantly to morbidity and mortality in patients requiring mechanical circulatory support and transplantation. There are no validated markers to predict major adverse kidney events (MAKEs), for w
Externí odkaz:
https://doaj.org/article/4190e414d9a0449a8f6e21bc586b2fe5
Autor:
Ning Song, Audrey I. Adji, Sara L. Hungerford, Mayooran J. Namasivayam, Christopher S. Hayward, Andrew Jabbour, David W. M. Muller
Publikováno v:
Hypertension Research. 46:730-741
Autor:
Mayooran Namasivayam, Thomas Meredith, David W.M. Muller, David Alexander Roy, Andrew K. Roy, Jason Ciril Kovacic, Christopher S. Hayward, Michael P. Feneley
Publikováno v:
Frontiers in Cardiovascular Medicine. 10
BackgroundModerate severity aortic stenosis (AS) is poorly understood, is associated with subclinical myocardial dysfunction, and can lead to adverse outcome rates that are comparable to severe AS. Factors associated with progressive myocardial dysfu
Autor:
Gina Chowdhury, Jane E. Carland, Shaun Kumar, Nick Olsen, Garry Graham, Gayathri Kumarasinghe, Christopher S. Hayward, Jerry R. Greenfield, Peter Macdonald, Richard O. Day, Sophie L. Stocker
Publikováno v:
British Journal of Clinical Pharmacology.
Autor:
Cassia Kessler Iglesias, Jim Pouliopoulos, Liza Thomas, Christopher S. Hayward, Andrew Jabbour, Diane Fatkin
Publikováno v:
Frontiers in Cardiovascular Medicine. 10
Changes in atrial size and function have historically been considered a surrogate marker of ventricular dysfunction. However, it is now recognized that atrial cardiomyopathy (ACM) may also occur as a primary myocardial disorder. Emerging evidence tha
Autor:
Audrey, Adji, Sajad, Shehab, Pankaj, Jain, Desiree, Robson, Paul, Jansz, Christopher S, Hayward
Publikováno v:
ASAIO Journal. 68:925-931
Durable continuous-flow left ventricular assist devices (cfLVADs) demonstrate superior survival, cardiac functional status, and overall quality of life compared to medical therapy alone in advanced heart failure. Previous studies have not considered